saga

Saga Diagnostics AB, a Lund, Sweden-based precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues, raised SEK 40m in financing (€3.7m, USD 4.1m).